Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients - PubMed (original) (raw)
Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients
J Malyszko et al. Transplant Proc. 2009 Jan-Feb.
Abstract
Background/aims: Few biomarkers exist to monitor chronic kidney disease (CKD). Neutrophil gelatinase-associated lipocalin (NGAL), a member of lipocalin family, has recently been proven useful to quantitate CKD. The aim of the study was to assess whether NGAL could represent a novel, sensitive marker of kidney function in adult patients with CKD and in kidney transplant recipients.
Methods: We studied possible relations between serum NGAL, creatinine, and estimated glomerular filtration rate (eGFR) in 80 nondiabetic patients with CKD stages 2 to 4; 80 nondiabetic kidney transplant recipients on a calcineurin inhibitor mycophenolate mofetil, or azathioprine as well as prednisone and in healthy volunteers (n = 32, mean age 50 years).
Results: Serum NGAL and creatinine values were significantly higher and eGFR significantly lower in kidney allograft recipients and patients with CKD compared with controls. NGAL rose gradually, reaching the higher value in stage 4 CKD. In univariate analysis serum NGAL was related to serum creatinine, hemoglobin, hematocrit, leukocyte count, and eGFR. Predictors of serum NGAL were creatinine and eGFR among patients with CKD. On univariate analysis serum NGAL was related to serum creatinine, urea, hemoglobin, hematocrit, white blood cell count, calcineurin concentration, eGFR, and albumin in kidney transplant recipients. On multiple regression analysis, predictors of NGAL were creatinine, calcineurin concentration, and high-sensitivity C-reactive protein. In healthy volunteers, serum NGAL correlated with age, serum creatinine, eGFR, and leukocyte count.
Conclusion: NGAL should be investigated as a potential early, sensitive marker of kidney impairment/injury, which might provide an additional accurate measure of kidney impairment in CKD and among transplant recipients, particularly at advanced stages.
Similar articles
- Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients.
Malyszko J, Malyszko JS, Mysliwiec M. Malyszko J, et al. Clin Transplant. 2009 Sep-Oct;23(5):681-6. doi: 10.1111/j.1399-0012.2009.01034.x. Epub 2009 Aug 25. Clin Transplant. 2009. PMID: 19708926 - Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
Przybylowski P, Malyszko J, Malyszko JS. Przybylowski P, et al. Transplant Proc. 2010 Jun;42(5):1797-802. doi: 10.1016/j.transproceed.2010.02.079. Transplant Proc. 2010. PMID: 20620526 - Neutrophil gelatinase-associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury in the emergency department.
Di Grande A, Giuffrida C, Carpinteri G, Narbone G, Pirrone G, Di Mauro A, Calandra S, Noto P, Le Moli C, Alongi B, Nigro F. Di Grande A, et al. Eur Rev Med Pharmacol Sci. 2009 May-Jun;13(3):197-200. Eur Rev Med Pharmacol Sci. 2009. PMID: 19673171 Review. - Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
Prabhu A, Sujatha DI, Ninan B, Vijayalakshmi MA. Prabhu A, et al. Ann Vasc Surg. 2010 May;24(4):525-31. doi: 10.1016/j.avsg.2010.01.001. Epub 2010 Apr 2. Ann Vasc Surg. 2010. PMID: 20363104 Review.
Cited by
- Urinary neutrophil gelatinase-associated lipocalin (uNGAL) and kidney injury molecule-1 (uKIM-1) as markers of active lupus nephritis.
Ibrahim WHM, Sabry AA, Abdelmoneim AR, Marzouk HFA, AbdelFattah RM. Ibrahim WHM, et al. Clin Rheumatol. 2024 Jan;43(1):167-174. doi: 10.1007/s10067-023-06698-2. Epub 2023 Jul 29. Clin Rheumatol. 2024. PMID: 37516706 Free PMC article. - Renal injury, biomarkers, and myositis, an understudied aspect of disease: prospective study in the MyoCite cohort.
Conticini E, Naveen R, Sen P, Singh M, Rathore U, Anuja AK, Rai MK, Yadav B, Prasad N, Agarwal V, Gupta L. Conticini E, et al. Front Med (Lausanne). 2023 Jun 22;10:1127657. doi: 10.3389/fmed.2023.1127657. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37425322 Free PMC article. - Urinary biomarkers in lupus nephritis.
Aragón CC, Tafúr RA, Suárez-Avellaneda A, Martínez MT, Salas AL, Tobón GJ. Aragón CC, et al. J Transl Autoimmun. 2020 Feb 13;3:100042. doi: 10.1016/j.jtauto.2020.100042. eCollection 2020. J Transl Autoimmun. 2020. PMID: 32743523 Free PMC article. Review. - Evaluation of early biomarkers of renal dysfunction in diabetic patients.
Al-Hazmi SF, Gad HGM, Alamoudi AA, Eldakhakhny BM, Binmahfooz SK, Alhozali AM. Al-Hazmi SF, et al. Saudi Med J. 2020 Jul;41(7):690-697. doi: 10.15537/smj.2020.7.25168. Saudi Med J. 2020. PMID: 32601635 Free PMC article. - Prediction of kidney failure in children with chronic kidney disease and obstructive uropathy.
Sebastião YV, Cooper JN, Becknell B, Ching CB, McLeod DJ. Sebastião YV, et al. Pediatr Nephrol. 2021 Jan;36(1):111-118. doi: 10.1007/s00467-020-04661-w. Epub 2020 Jun 25. Pediatr Nephrol. 2021. PMID: 32583045 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous